Cargando…
Nigella sativa and Trigonella foenum-graecum Supplemented Chapatis Safely Improve HbA1c, Body Weight, Waist Circumference, Blood Lipids, and Fatty Liver in Overweight and Diabetic Subjects: A Twelve-Week Safety and Efficacy Study
In 2019, ∼ 463 million people globally had diabetes mellitus (DM), with China (25.1%), India (16.6%), and the United States (6.69%) representing nearly 50% of that total. The primary objectives of this exploratory study were to assess the safety and potential efficacy of Nigella sativa and fenugreek...
Autores principales: | Rao, Amit S., Hegde, Shyamala, Pacioretty, Linda M., DeBenedetto, Jan, Babish, John G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478223/ https://www.ncbi.nlm.nih.gov/pubmed/32758056 http://dx.doi.org/10.1089/jmf.2020.0075 |
Ejemplares similares
-
In Vitro Anti-plasmodial activity of Trigonella foenum–graecum L.
por: Palaniswamy, M., et al.
Publicado: (2010) -
Effects of Saponin from Trigonella Foenum-Graecum Seeds on Dyslipidemia
por: Chen, Zhi, et al.
Publicado: (2017) -
Revisiting Trigonella foenum-graecum L.: Pharmacology and Therapeutic Potentialities
por: Visuvanathan, Theysshana, et al.
Publicado: (2022) -
Potential pharmacodynamic and pharmacokinetic interactions of Nigella Sativa and Trigonella Foenum-graecum with losartan in L-NAME induced hypertensive rats
por: Ahad, Abdul, et al.
Publicado: (2020) -
Assessment of genetic diversity in Trigonella foenum-graecum and Trigonella caerulea using ISSR and RAPD markers
por: Dangi, Rakhee S, et al.
Publicado: (2004)